Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NCCAM Funding For Botanical/HIV Drug Interaction Research Set At $600,000

This article was originally published in The Tan Sheet

Executive Summary

Grant requests for Phase I/II clinical studies on botanicals' interaction with HIV drugs should "examine the pharmacokinetics or pharmacodynamics of the botanical/drug combination" compared to lone use of either product, the National Center for Complementary & Alternative Medicine says
Advertisement

Related Content

CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM
CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM
CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM
Garlic Supplements, Protease Inhibitor Interactions Troublesome – NIH Study
NCCAM Slowing Research Pace, Turning To Program Announcements
NCCAM Slowing Research Pace, Turning To Program Announcements

Topics

Advertisement
UsernamePublicRestriction

Register

PS093408

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel